Parkinson's drug may hide immune danger: new study investigates
NCT ID NCT06634641
First seen Nov 19, 2025 · Last updated May 14, 2026 · Updated 23 times
Summary
This study looks at whether clozapine, a drug used to treat psychosis in Parkinson's disease, can weaken the immune system over time. Researchers will measure immune cells and antibodies in 24 patients before and after 6 months and 1 year of treatment. The goal is to understand if long-term use increases infection risk, which could help doctors monitor patients more carefully.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSYCHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Amiens-Picardie
RECRUITINGSalouël, 80480, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.